Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 861177 NEW YORK, NY

Position in DNTH

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$7,349,599
+$2,277,897 QoQ
Shares Held
75,396
+24.8% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 269 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority Sole 34% Shared 0% None 66%

Common Shares in DNTH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. DNTH ranks #50 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNTH

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,349,599 75,396
2026-03-31 $5,071,702 60,435
2025-12-31 $497,527 12,073
2024-06-30 $262,733 10,152
2021-09-30 MGTA 511,542
2021-06-30 MGTA 523,034
2021-03-31 MGTA 561,207
2020-12-31 MGTA 557,667
2020-09-30 MGTA 609,572
2020-06-30 MGTA 600,000